Pharmaq invests in production
Norwegian fish vaccine manufacturer Pharmaq has chosen to invest heavily in large-scale GMP production of viruses for fish vaccines in a new facility at Kløfta, its largest ever investment.

This is a syndicated post. Read the original at World Fishing & Aquaculture - News 2015-04-16.


Be the first to comment!

Leave a Reply